Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (11) GO Terms (0) Nucleotides (106) Proteins (38) Interactants (30) Wiki
XB-GENEPAGE-1014580

Papers associated with c4bpa



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

Exploring generic principles of compartmentalization in a developmental in vitro model., Gires PY, Thampi M, Krauss SW, Weiss M., Development. February 15, 2023; 150 (3):             

A nine amino acid domain is essential for mutant prion protein toxicity., Westergard L, Turnbaugh JA, Harris DA., J Neurosci. September 28, 2011; 31 (39): 14005-17.

Regulator of complement activation (RCA) gene cluster in Xenopus tropicalis., Oshiumi H, Suzuki Y, Matsumoto M, Seya T., Immunogenetics. May 1, 2009; 61 (5): 371-84.  

Mutagenesis studies in transgenic Xenopus intermediate pituitary cells reveal structural elements necessary for correct prion protein biosynthesis., van Rosmalen JW, Martens GJ., Dev Neurobiol. May 1, 2007; 67 (6): 715-27.        

Prion protein from Xenopus laevis: overexpression in Escherichia coli of the His-tagged protein and production of polyclonal antibodies., Pagliato L, Negri A, Nonnis S, Taverna F, Sangiorgio L, Ronchi S, Tedeschi G., Protein Expr Purif. April 1, 2006; 46 (2): 489-94.

Prion protein mRNA expression in Xenopus laevis: no induction during melanotrope cell activation., van Rosmalen JW, Born JM, Martens GJ., Dev Biol. February 23, 2006; 1075 (1): 20-5.        

The human prion octarepeat fragment prevents and reverses the inhibitory action of copper in the P2X4 receptor without modifying the zinc action., Lorca RA, Chacón M, Barría MI, Inestrosa NC, Huidobro-Toro JP., J Neurochem. May 1, 2003; 85 (3): 709-16.

Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein., Nunziante M, Gilch S, Schätzl HM., J Biol Chem. February 7, 2003; 278 (6): 3726-34.

Complement and Reactants of Acute Phase of Inflammation in the Processes of Functional Activity of Non-Specific Resistance and Immunoregulation., Nazarov PG., Russ J Immunol. October 1, 1999; 4 (3): 247-250.

Determinants of carboxyl-terminal domain translocation during prion protein biogenesis., De Fea KA, Nakahara DH, Calayag MC, Yost CS, Mirels LF, Prusiner SB, Lingappa VR., J Biol Chem. June 17, 1994; 269 (24): 16810-20.

Evidence for a secretory form of the cellular prion protein., Hay B, Prusiner SB, Lingappa VR., Biochemistry. December 15, 1987; 26 (25): 8110-5.

???pagination.result.page??? 1